They are behind schedule if you go off ANZCTR status.
Last update was the preso which indicated Gingivitis at In Vivo studies and almost out of preclin and the other 3 at the stage just before that.
Do hope for news soon but until IHL gives an update to the market we are still in the dark. Could be a week, could be a month could even be two. Who knows.
